Back to search
FDAFDA · Food and drugs·Recall number D-0117-2018

NitroGlycerin 100 mcg/mL QS 5% Dextrose Inj, USP (2 mg per 20 mL) 20 mL Sterile single dose syringe, packaged in 10 x 5 (FIFTY) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054, NDC 15082-818-62.

Published December 27, 2017 · Recall initiated: June 9, 2017

Summary

FDA records drug Class II recall D-0117-2018, published December 27, 2017 and initiated June 9, 2017. Recalling firm: Advanced Pharma Inc.; Status: Terminated; Reported quantity: 50 syringes; Lot: Lot: 5/31/17 0202 5-81862S, BUD 7/30/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Advanced Pharma Inc.
Distributor
Nationwide in the USA to hospitals and medical facilities.
Lot
Lot: 5/31/17 0202 5-81862S, BUD 7/30/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was NitroGlycerin 100 mcg/mL QS 5% Dextrose Inj, USP (2 mg per 20 mL) 20 mL Sterile single dose syringe, packaged in 10 x 5 (FIFTY) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054, NDC 15082-818-62. recalled?

Yes. FDA published recall D-0117-2018 on December 27, 2017. Reported hazard: Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

What should I do if I have this product?

Voluntary: Firm initiated · Letter